Dapiprazole

In this article, we will explore the fascinating world of Dapiprazole. From its origin to its evolution over time, we will delve into its meaning, its importance and its impact on today's society. We will analyze its different facets, from its relevance in the scientific field to its influence on popular culture. Through a multidisciplinary approach, we will highlight the diverse perspectives that exist around Dapiprazole, offering a comprehensive and enriching vision. Thus, we will discover how Dapiprazole has marked a milestone in history and remains a topic of study and debate today.
Dapiprazole
Clinical data
AHFS/Drugs.comConsumer Drug Information
MedlinePlusa601043
Pregnancy
category
  • B
Routes of
administration
Topical (eye drops)
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityNegligible when administered topically
Identifiers
  • 3-{2-ethyl}-5,6,7,8-tetrahydro-triazolopyridine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H27N5
Molar mass325.460 g·mol−1
3D model (JSmol)
  • n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
  • InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 checkY
  • Key:RFWZESUMWJKKRN-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.[1]

References

  1. ^ Doughty MJ, Lyle WM (May 1992). "A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation". Optometry and Vision Science. 69 (5): 358–68. doi:10.1097/00006324-199205000-00005. PMID 1350669. S2CID 22781280.